These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 23971638

  • 1. Cardiovascular complications in autosomal dominant polycystic kidney disease.
    Ecder T.
    Curr Hypertens Rev; 2013 Feb; 9(1):2-11. PubMed ID: 23971638
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.
    Ecder T, Schrier RW.
    Nat Rev Nephrol; 2009 Apr; 5(4):221-8. PubMed ID: 19322187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
    Pietrzak-Nowacka M, Safranow K, Płońska-Gościniak E, Nowacki A, Późniak P, Gutowski P, Ciechanowski K.
    Kidney Blood Press Res; 2024 Apr; 49(1):9-19. PubMed ID: 38096797
    [Abstract] [Full Text] [Related]

  • 5. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
    Sans L, Pascual J, Radosevic A, Quintian C, Ble M, Molina L, Mojal S, Ballarin JA, Torra R, Fernández-Llama P.
    Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
    [Abstract] [Full Text] [Related]

  • 6. [ADPKD and Heart].
    Liut F, Izzi C, Dallera N, Scolari F.
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):119-130. PubMed ID: 28682033
    [Abstract] [Full Text] [Related]

  • 7. Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.
    Tkachenko O, Helal I, Shchekochikhin D, Schrier RW.
    Curr Hypertens Rev; 2013 Feb; 9(1):12-20. PubMed ID: 23971639
    [Abstract] [Full Text] [Related]

  • 8. [Cardiovascular risk in polycystic kidney disease].
    Di Lorenzo A, Stallone G, Infante B, Grandaliano G, Schena FP.
    G Ital Cardiol (Rome); 2015 Sep; 16(9):479-84. PubMed ID: 26418387
    [Abstract] [Full Text] [Related]

  • 9. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW.
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [Abstract] [Full Text] [Related]

  • 10. Update on pathogenesis, management, and treatment of hypertension in autosomal dominant polycystic kidney disease.
    Helal I, Al-Rowaie F, Abderrahim E, Kheder A.
    Saudi J Kidney Dis Transpl; 2017 Sep; 28(2):253-260. PubMed ID: 28352004
    [Abstract] [Full Text] [Related]

  • 11. Optimal care of autosomal dominant polycystic kidney disease patients.
    Schrier RW.
    Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW.
    J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
    [Abstract] [Full Text] [Related]

  • 13. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.
    Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kasikcioglu E, Alisir S, Tufan F, Namli S, Uysal M, Ecder T.
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):986-91. PubMed ID: 18354076
    [Abstract] [Full Text] [Related]

  • 14. Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease.
    Oflaz H, Alisir S, Buyukaydin B, Kocaman O, Turgut F, Namli S, Pamukcu B, Oncul A, Ecder T.
    Kidney Int; 2005 Nov; 68(5):2244-9. PubMed ID: 16221225
    [Abstract] [Full Text] [Related]

  • 15. Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).
    Cadnapaphornchai MA.
    Curr Hypertens Rev; 2013 Feb; 9(1):21-6. PubMed ID: 23971640
    [Abstract] [Full Text] [Related]

  • 16. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR, Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [Abstract] [Full Text] [Related]

  • 17. Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients.
    Lai S, Perrotta AM, Bagordo D, Mazzaferro S, Menè P, Gigante A, Tinti F, Galani A, Cianci R.
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6333-6338. PubMed ID: 34730214
    [Abstract] [Full Text] [Related]

  • 18. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW.
    Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F, Williams O, Chapman A.
    Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.